Aileen Health
Aileen Health is revolutionizing healthcare with its AI-powered disease trajectory prediction technology, ai:leen. This platform analyzes medical images to forecast disease progression, enabling earlier detection and personalized treatment decisions. Targeting oncology and neurological diseases, ai:leen aims to support pharma clinical trials and eventually patient care by identifying fast-progressing diseases and predicting outcomes under treatment. The company leverages patented generative AI technology trained on breast and brain images, with plans to expand to lung and prostate cancers, as well as conditions like Multiple Sclerosis, ALS, Huntington's disease, and Parkinson's. Their approach offers earlier disease detection, fewer missed diagnoses, and better treatment matching, particularly benefiting underserved populations like Black women who have higher mortality rates from certain cancers.
Aileen Health
Aileen Health is revolutionizing healthcare with its AI-powered disease trajectory prediction technology, ai:leen. This platform analyzes medical images to forecast disease progression, enabling earlier detection and personalized treatment decisions. Targeting oncology and neurological diseases, ai:leen aims to support pharma clinical trials and eventually patient care by identifying fast-progressing diseases and predicting outcomes under treatment. The company leverages patented generative AI technology trained on breast and brain images, with plans to expand to lung and prostate cancers, as well as conditions like Multiple Sclerosis, ALS, Huntington's disease, and Parkinson's. Their approach offers earlier disease detection, fewer missed diagnoses, and better treatment matching, particularly benefiting underserved populations like Black women who have higher mortality rates from certain cancers.